E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/21/2006 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

New Issue: WEX Pharmaceuticals announces C$2.06 million placement of stock

By Laura Lutz

Des Moines, Aug. 21 - WEX Pharmaceuticals Inc. plans to complete a C$2.06 million private placement of shares with investors in China.

The company will sell 7,773,584 shares at C$0.265 each.

The deal is expected to close Sept. 8.

Proceeds will be used for general working capital.

WEX Pharmaceuticals is a Vancouver, B.C., drug company focused on pain treatment.

Issuer:WEX Pharmaceuticals Inc.
Issue:Stock
Amount:C$2,059,999.76
Shares:7,773,584
Price:C$0.265
Warrants:No
Pricing date:Aug. 21
Stock symbol:TSX Venture: WXI
Stock price:C$0.325 at close Aug. 21

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.